All products

AstraZeneca receives regulatory boost for...

AstraZeneca received a double boost for its oncology portfolio on Tuesday, after US and European regulators accepted regulatory submissions for its drugs, the first step towards winning approval for these medicines. ...

Top 7 Trends In Pharmaceutical Research I...

Being under ever-increasing pressure to compete in a challenging economic and technological environment, pharmaceutical and biotech companies must continually innovate in their R&D programmes to stay ahead ...

ARS-1620: A promising new inhibitor for K...

According to a study published in Cell, researchers have developed a specific inhibitor for KRASG12C called ARS-1602 that induced tumor regression in mice. “This study provides in vivo evidence that mutant KRAS can be...

All products

(R)-(5-(3,5-difluorophenyl)-4,5-dihydro-1H-pyra...

BDTX-189

(S)-7-methoxy-2-methyl-6-((tetrahydrofuran-3-yl...

Chenodeoxycholic Acid

tert-butyl 4-(5-(3,5-difluorophenyl)-4,5-dihydr...

6-bromo-1,5-dimethylpyrimidine-2,4(1H,3H)-dione

3-Nitrosalicylic acid

SEP-363856 HCl

BAY-985

BGJ-398

MRTX849

1267502-34-0

2414349-93-0

202413-65-8

79200-57-0

2101518-75-4

2074702-04-6

58494-23-8

1511303-08-4

1532317-46-6

1535376-79-4

1396777-69-7

EEDi-5285

BI-4924

CJ-2360

BMS-986260

BAY-899

Piperogalin

Grifolin

Cannabigerol

AstraZeneca receives regulatory boost for...

Top 7 Trends In Pharmaceutical Research I...

ARS-1620: A promising new inhibitor for K...

AstraZeneca receives regulatory boost for...

Top 7 Trends In Pharmaceutical Research I...